MedTrace Logo

Pegylated Interferon and Ribavirin in Hepatitis C Patients on Opioid Pharmacotherapy

NCT01120795 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2024-01-30

No results posted yet for this study

Summary

The purpose of this study is to see if treatment of chronic hepatitis C in people who are on opiate replacement therapy such as methadone or buprenorphine (including patient who still inject drugs) is safe and effective.

Conditions

  • Chronic Hepatitis C

Interventions

DRUG

Pegylated interferon and ribavirin

Pegylated interferon 180 ug subcutaneous per week Ribavirin 1000-1200 mg /day for genotype 1 and 800 mg /day orally for genotype non 1 Duration: 48 weeks for genotype 1 and 24 weeks for gentoype non 1

DRUG

Pegylated interferon and ribavirin

Pegylated interferon 180 ug/ week subcutaneously Ribavrin 1000-1200 mg /day for genotype 1 and 800 mg/day orally for genotype 2 and 3 Treatment duration 48 weeks for genotype 1 and 24 weeks for genotypes 2 and 3

Sponsors & Collaborators

  • The University of New South Wales

    collaborator OTHER

  • St Vincent's Hospital, Sydney

    collaborator OTHER

  • Western Hospital, Australia

    collaborator OTHER_GOV

  • Monash University

    collaborator OTHER

  • Hoffmann-La Roche

    collaborator INDUSTRY

  • Melbourne Health

    lead OTHER

Principal Investigators

  • Joseph J Sasadeusz, MBBS · Melbourne Health

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-02-29
Primary Completion
2006-01-31
Completion
2006-07-31

Countries

  • Australia

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01120795 on ClinicalTrials.gov